Parent advocates have been urging changes to a policy that sets out responsibilities of school boards, principals and staff when it comes to children with anaphylaxis, asthma, diabetes and epilepsy.
A new study suggests that patients are at increased risk of drug toxicity even before treatment begins, at the start of treatment, and when combined with benzodiazepines and opioids.
Kisunla (donanemab) is a new IV anti-amyloid beta-directed monoclonal antibody for adults with mild cognitive impairment or mild dementia due to Alzheimer's disease.
Small struggles can be brushed off as part of aging or blamed on a busy mind. Yet, when these new difficulties persist over time, they may be more than just minor frustrations; they might be early signs of something far deeper.
